Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.
VTE
1 other identifier
observational
386
0 countries
N/A
Brief Summary
Study Title:Assessment of Adherence to Guidelines for Thromboprophylaxis in a Tertiary United Arab Emirates (UAE) hospital Study Site: Al Qassimi Hospital, United Arab Emirates Study Objectives: The primary objective of this study is assessment of appropriateness of VTE prophylaxis administered to critically ill and surgical patients for whom pharmacologic treatment is indicated according to the American College of Chest Physicians (ACCP) 2012 guidelines. The secondary objective is to: 1.Identify some causes of inadequate VTE prophylaxis in different patient populations, such as prescribing problems and errors at the level of administration. Study Design: Cross sectional retrospective observational study Sample size: Approximately 400 Study Population: Inclusion criteria Patients who meet the following criteria will be included:
- 1.Patients aged 18 and above.
- 2.Patients admitted to any of the critical care units, or the general or orthopaedic surgical wards.
- 3.Patients who have been in hospital more than 24 hours.
- 4.Caprini score \> 1 (see procedure)
- 5.Patients who have been admitted to a critical care unit and transferred out to a non surgical unit within 24 hours of admission.
- 6.Patients receiving oral anticoagulant therapy for indications other than VTE prophylaxis or treatment, such as atrial fibrillation and prosthetic heart valves.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2013
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 29, 2013
CompletedFirst Posted
Study publicly available on registry
October 9, 2013
CompletedOctober 9, 2013
October 1, 2013
7 months
September 29, 2013
October 8, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients receiving inappropriate or inadequate VTE prophylaxis
Case Report Form Analysis Form
2 weeks
Secondary Outcomes (1)
Number of patients receiving inadequate VTE prophylaxis due to medication errors, missed doses etc.
2 weeks
Eligibility Criteria
The targe sample is paients in critical care wards and orthopaedic surgery patients. All patients will be screened at discharge. Those who fulfill the inclusion/exclusion criteria will go on to have a thromboembolism risk assessment using the CapriniRisk Assessment Model. Those who have a score \> 1 will be included for assessment of their VTE prophylaxis (from medical records). Approximately 60 patients are admitted into critical care units and 40 general and orthopaedic surgical patients are admitted to the surgical wards per month, giving a total sample of around 400 patients.
You may qualify if:
- Patients aged 18 and above.
- Patients admitted to any of the critical care units, or the general or orthopaedic surgical wards.
- Patients who have been in hospital more than 24 hours.
- Caprini score \> 1 (see procedure)
You may not qualify if:
- Patients who have been admitted to a critical care unit and transferred out to a non surgical unit within 24 hours of admission.
- Patients receiving oral anticoagulant therapy for indications other than VTE prophylaxis or treatment, such as atrial fibrillation and prosthetic heart valves.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ghada Al Tajir, Ph.D
Clinical Research Centre, Ministry of Health, United Arab Emirates
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Clinical Research Centre
Study Record Dates
First Submitted
September 29, 2013
First Posted
October 9, 2013
Study Start
January 1, 2013
Primary Completion
August 1, 2013
Study Completion
September 1, 2013
Last Updated
October 9, 2013
Record last verified: 2013-10